$2.59 Billion is the total value of HealthCor Management, L.P.'s 54 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 48.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IQV | Sell | IQVIA HLDGS INC | $143,929,000 | +8.6% | 803,310 | -4.5% | 5.55% | +4.6% |
| HCA | Sell | HCA HEALTHCARE INC | $116,971,000 | +1.3% | 711,240 | -23.2% | 4.51% | -2.4% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $100,342,000 | -25.2% | 902,601 | -20.1% | 3.87% | -27.9% |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $95,945,000 | -26.6% | 6,937,448 | -21.8% | 3.70% | -29.3% |
| ABBV | Sell | ABBVIE INC | $91,469,000 | -20.8% | 853,650 | -35.3% | 3.53% | -23.7% |
| HUM | Sell | HUMANA INC | $90,334,000 | -4.7% | 220,181 | -3.8% | 3.48% | -8.1% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $84,963,000 | -52.2% | 551,384 | -57.8% | 3.28% | -54.0% |
| MDT | Sell | MEDTRONIC PLC | $70,770,000 | -51.4% | 604,150 | -56.9% | 2.73% | -53.2% |
| GH | Sell | GUARDANT HEALTH INC | $70,002,000 | -21.5% | 543,160 | -31.9% | 2.70% | -24.3% |
| RPRX | Sell | ROYALTY PHARMA PLC | $67,043,000 | +6.5% | 1,339,530 | -10.5% | 2.58% | +2.6% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $61,365,000 | -61.5% | 174,990 | -65.8% | 2.37% | -62.9% |
| NVRO | Sell | NEVRO CORP | $27,012,000 | -73.5% | 156,046 | -78.7% | 1.04% | -74.4% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $26,935,000 | -50.9% | 107,800 | -55.5% | 1.04% | -52.7% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $21,706,000 | -75.7% | 226,460 | -75.6% | 0.84% | -76.5% |
| THC | Sell | TENET HEALTHCARE CORP | $17,227,000 | -37.0% | 431,441 | -61.3% | 0.66% | -39.3% |
| TFX | Sell | TELEFLEX INCORPORATED | $5,412,000 | -90.4% | 13,150 | -92.0% | 0.21% | -90.7% |
| INCY | Sell | INCYTE CORP | $1,699,000 | -16.1% | 19,530 | -13.5% | 0.07% | -18.5% |
| OM | Exit | OUTSET MED INC | $0 | – | -35,000 | -100.0% | -0.07% | – |
| DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -120,000 | -100.0% | -0.10% | – |
| ATHA | Exit | ATHIRA PHARMA INC | $0 | – | -217,500 | -100.0% | -0.16% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -14,680 | -100.0% | -0.19% | – |
| AMWL | Exit | AMERICAN WELL CORPcl a | $0 | – | -250,000 | -100.0% | -0.30% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -519,490 | -100.0% | -0.34% | – |
| ARCT | Exit | ARCTURUS THERAPEUTICS HLDGScall | $0 | – | -200,000 | -100.0% | -0.34% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -345,550 | -100.0% | -0.64% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INCcall | $0 | – | -310,000 | -100.0% | -0.93% | – |
| SYK | Exit | STRYKER CORPORATION | $0 | – | -118,550 | -100.0% | -0.99% | – |
| DHR | Exit | DANAHER CORPORATION | $0 | – | -144,600 | -100.0% | -1.25% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -578,030 | -100.0% | -1.73% | – |
| MD | Exit | MEDNAX INC | $0 | – | -3,234,280 | -100.0% | -2.11% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -233,740 | -100.0% | -2.38% | – |
| ARCT | Exit | ARCTURUS THERAPEUTICS HLDGS | $0 | – | -1,594,452 | -100.0% | -2.74% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -190,310 | -100.0% | -4.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.